scispace - formally typeset
J

Jamie Case

Researcher at Scripps Health

Publications -  73
Citations -  2864

Jamie Case is an academic researcher from Scripps Health. The author has contributed to research in topics: Progenitor cell & CD34. The author has an hindex of 22, co-authored 72 publications receiving 2703 citations. Previous affiliations of Jamie Case include Indiana University – Purdue University Indianapolis & Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Novel Markers of Angiogenesis in the Setting of Cognitive Impairment and Dementia

TL;DR: A significant association between angiogenesis activity and cerebrovascular disease is demonstrated and is associated with increased white matter hyperintensities among subjects with mild cognitive impairment.
Journal ArticleDOI

Lung parenchymal development in premature infants without bronchopulmonary dysplasia.

TL;DR: While infants who are born extremely premature and develop bronchopulmonary dysplasia have impaired alveolar development and decreased pulmonary diffusion (DLCO), it remains unclear whether infants born less premature and do not develop BPD, healthy premature (HP), have impaired parenchymal development.
Journal ArticleDOI

Prior Cryopreservation of Ex Vivo-Expanded Cord Blood Cells Is Not Detrimental to Engraftment as Measured in the NOD-SCID Mouse Model

TL;DR: Results suggest that prior cryopreservation does not prevent expanded cells engrafting in NOD-SCID mice and suggest that SCID Engrafting Potential (SEP) is higher than freshly expanded CD34(+) cells.
Journal ArticleDOI

Membrane and capillary components of lung diffusion and pro-angiogenic cells in infants

TL;DR: The parallel increase in the membrane and vascular components of pulmonary diffusion is consistent with alveolarisation during this period of rapid lung growth, and the relationship between pCHSPCs and VC suggest that pro-angiogenic cells may contribute to this vascular process.
Journal ArticleDOI

Prolonged ex vivo culture of cord blood CD34+ cells facilitates myeloid and megakaryocytic engraftment in the non‐obese diabetic severe combined immunodeficient mouse model

TL;DR: Analysis of SCID engrafting potential showed that prolongation of culture duration facilitates in vivo expansion of CD45+, CD34+ and CD19+ cells after transplantation, and it is anticipated that prolonged ex vivo culture of CB will have a beneficial clinical effect.